Medications for Older Persons : Recommendations, Harms, Evidence

個数:
  • 予約

Medications for Older Persons : Recommendations, Harms, Evidence

  • 現在予約受付中です。出版後の入荷・発送となります。
    重要:表示されている発売日は予定となり、発売が延期、中止、生産限定品で商品確保ができないなどの理由により、ご注文をお取消しさせていただく場合がございます。予めご了承ください。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 300 p.
  • 言語 ENG
  • 商品コード 9780443290251

Full Description

Medications for Older Persons: Recommendations, Harms, Evidence provides a comprehensive resource detailing the benefits of medications for older individuals. It also addresses the potential harms associated with the prescription of potentially inappropriate medications or omissions in prescribing and examines how many adverse events, rehospitalizations, and deaths can be attributed to these medications. The book opens with a summary of medications that most benefit older patients, followed by the impact of older persons' alcohol consumption, self-medication, and medication list accuracy and how these factors correlate to health outcomes.

The remainder of the book is devoted to the assessment of medication groups focusing on Numbers Needed to Treat, Numbers Needed to Harm, and characteristics and numbers of adverse events. Medication groups covered include cardiovascular, central nervous system, renal, gastrointestinal, musculoskeletal, respiratory, endocrine, pain, and fall prevention.

Contents

Section 1. Recommendations for medications of older persons
1. A summary of medications that most benefit older patients: for clinicians, patients, their families, policy makers and health ministries
2. STOPP and American Geriatrics Society "potentially inappropriate medications" (PIMs) and START "potential prescribing omissions" (PPOs)
3. The Calgary study of 295,706 admissions of older persons to four acute care hospitals 2013-2021
4. Adverse drug interactions in the Veterans Affairs Adverse Drug Event Reporting System
5. Pharmacokinetics and pharmacodynamics in older persons
6. Methods to identify adverse drug interactions and effects
7. How personalized medicine has changed senior patient outcomes at the Mayo Clinic and other centers

Section 2. Older persons alcohol consumption, self-medication, and medication list accuracy
8. Older persons alcohol consumption
9. Self-medication and over the counter medications by older persons
10. The accuracy of recording medication lists, transferring lists between community practitioners and medical institutions, and the potential effects on the accuracy of assessing PIMs, PPOs and adverse medication events

Section 3. Cardiovascular medications
11. Medications for hypertension
12. Medications for heart failure
13. Medications for arrhythmias
14. Medications for diuresis
15. Medications for coagulation

Section 4. Central Nervous System medications
16. Medications for depression
17. Medications for anxiety
18. Medications for insomnia
19. Neuroleptic/antipsychotic medications
20. Avoiding medications with risks of delirium
21. Avoiding medications that augment dementia

Section 5. Renal medication
22. Prescribing to reduce risks of renal insufficiency and failure

Section 6. Gastrointestinal medications
23. Prescribing to reduce the risks of peptic ulcer disease, gastritis, and esophagitis and treat if present
24. Prescribing to reduce the risks of constipation or diarrhea

​​​​​​​Section 7. Musculoskeletal medications
25. Medications for arthritis
26. Medications for osteoporosis

Section 8. Respiratory medications
27. Medications for COPD

Section 9. Endocrine medications
28. Medications for diabetes

Section 10. Pain medications
29. Non-opioid analgesics and opioids for seniors

Section 11. Changing prescribing to prevent falls
30. Prescribing to prevent falls

最近チェックした商品